Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections
Emergence and re-emergence of respiratory virus infections represent a significant threat to global public health, as they occur seasonally and less frequently (such as in the case of influenza virus) as pandemic infections. Some of these viruses have been in the human population for centuries and o...
Main Authors: | Mohammad Amin Behzadi, Victor H. Leyva-Grado |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.01327/full |
Similar Items
-
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01) -
Respiratory Syncytial Virus Infection: Treatments and Clinical Management
by: Shiza Malik, et al.
Published: (2023-02-01) -
Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
by: Yong Shik Kwon, et al.
Published: (2017-12-01) -
Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies
by: Dvorkin J, et al.
Published: (2023-01-01) -
Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants
by: Ziwei Hu, et al.
Published: (2021-06-01)